Oncolytics Biotech Inc. (ONCY) Financials

ONCY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 8.2 million 9.5 million
Dec. 31, 2025 7.6 million 11.4 million
Sept. 30, 2025 15.1 million 10.7 million
June 30, 2025 20.0 million 10.2 million

ONCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -10.2 million 3.2 million
Dec. 31, 2025 -6.3 million -2.7 million
Sept. 30, 2025 -6.7 million 4.1 million
June 30, 2025 -5.5 million 523000

ONCY Net Income

No data available :(

ONCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.5 million - 245255
Dec. 31, 2025 5.2 million - 563000
Sept. 30, 2025 12.4 million - 835000
June 30, 2025 14.6 million - 888000

ONCY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 112.3 million
Dec. 31, 2025 95.9 million
Sept. 30, 2025 101.3 million
June 30, 2025 91.0 million

ONCY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6000 4.6 million 4.7 million -
Dec. 31, 2025 935 1.1 million 2.2 million -
Sept. 30, 2025 5027 5.4 million 4.5 million -
June 30, 2025 - 2.1 million 2.1 million -

ONCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 22313
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

ONCY

Price: $0.96

52 week price:
0.33
1.51

Earnings Per Share: -0.32 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 110000

Market Capitalization: 87.0 million

Links: